FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease CNBCWith expanded FDA nod for RSV shot Abrysvo, Pfizer gains edge on GSK's Arexvy. But will it amount to much? FiercePharmaHealthCentral: Which RSV Vaccine Is Right for You? Cedars-SinaiGSK's Arexvy Vaccine Shows Strong Efficacy Against RSV in Older Adults AJMC.com Managed Markets Network